Zobrazeno 1 - 10 of 660 pro vyhledávání: '"Romatowski J"'
1
Akademický článek
Baseline Serum and Stool Microbiome Biomarkers Predict Clinical Efficacy and Tissue Molecular Response After Ritlecitinib Induction Therapy in Ulcerative Colitis.
Autor: Hassan-Zahraee M; Pfizer Inc, Cambridge, MA, USA., Ye Z; Pfizer Inc, Cambridge, MA, USA., Xi L; Pfizer Inc, Cambridge, MA, USA., Dushin E; Pfizer Inc, Cambridge, MA, USA., Lee J; Pfizer Inc, Cambridge, MA, USA., Romatowski J; Provincial Complex Hospital, Gastroenterology, Bialystok, Poland., Leszczyszyn J; Melita Medical, Gastroenterology, Wroclaw, Poland., Danese S; IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milan, Italy., Sandborn WJ; University of California San Diego, La Jolla, CA, USA., Banfield C; Pfizer Inc, Cambridge, MA, USA., Gale JD; Pfizer Inc, Cambridge, MA, USA., Peeva E; Pfizer Inc, Cambridge, MA, USA., Longman RS; Weill Cornell Medicine, Division of Gastroenterology and Hepatology, New York, NY, USA., Hyde CL; Pfizer Inc, Cambridge, MA, USA., Hung KE; Pfizer Inc, Cambridge, MA, USA.
Publikováno v: Journal of Crohn's & colitis [J Crohns Colitis] 2024 Sep 03; Vol. 18 (9), pp. 1361-1370.
Zobrazit plný text záznamu
2
Akademický článek
Oral Ritlecitinib and Brepocitinib for Moderate-to-Severe Ulcerative Colitis: Results From a Randomized, Phase 2b Study.
Autor: Sandborn WJ; University of California San Diego, La Jolla, California. Electronic address: wsandborn@health.ucsd.edu., Danese S; Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milan, Italy., Leszczyszyn J; Melita Medical, Gastroenterology, Wroclaw, Poland., Romatowski J; Provincial Complex Hospital, Gastroenterology, Bialystok, Poland., Altintas E; Mersin University, Gastroenterology, Mersin, Turkey., Peeva E; Pfizer Global Research and Development, Cambridge, Massachusetts., Hassan-Zahraee M; Pfizer Inc, Early Clinical Development, Cambridge, Massachusetts., Vincent MS; Pfizer Inc, Early Clinical Development, Cambridge, Massachusetts., Reddy PS; Pfizer Inc, Early Clinical Development, Cambridge, Massachusetts., Banfield C; Pfizer Inc, Early Clinical Development, Cambridge, Massachusetts., Salganik M; Pfizer Inc, Early Clinical Development, Cambridge, Massachusetts., Banerjee A; Pfizer Inc, Early Clinical Development, Cambridge, Massachusetts., Gale JD; Pfizer Inc, Early Clinical Development, Cambridge, Massachusetts., Hung KE; Pfizer Inc, Early Clinical Development, Cambridge, Massachusetts.
Publikováno v: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2023 Sep; Vol. 21 (10), pp. 2616-2628.e7. Date of Electronic Publication: 2023 Jan 06.
Zobrazit plný text záznamu
3
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
Autor: Sands BE1, Peyrin-Biroulet L1, Loftus EV Jr1, Danese S1, Colombel JF1, Törüner M1, Jonaitis L1, Abhyankar B1, Chen J1, Rogers R1, Lirio RA1, Bornstein JD1, Schreiber S1, Calvo S, Gimenez E, Resk JH, Tron EP, Al-Ansari M, Andrews J, Bampton P, Debinski H, Hendy P, Holtmann G, Leong R, Moore G, Hindryckx P, Barac T, Draganova R, Kotzev I, Marinova I, Markov M, Mihaylov Y, Pavlov D, Penkova M, Petrov A, Spassova Z, Stoyanova D, Velev E, Vladimirov B, Yanev F, Axler J, Fedorak R, Fowler S Jr, Halder S, Jairath V, Ponich T, Wong K, Baez E, Ricardo J, Velasquez M, Banic M, Bogadi I, Borzan V, Zgrablic JC, Duvnjak M, Gusej M, Krznaric Z, Cechova I, Hala T, Janu L, Kohout P, Lukas M, Machkova M, Matous J, Ulbrych J, Vanasek T, Klinge L, Rannem T, Theede K, Borissova J, Kull K, Amil M, Bouhnik Y, Gilleta C, Fumery M, Grimaud JC, Hebuterne X, Laharie D, Moreau J, Peyrin-Biroulet L, Roblin X, Baumgart D, Buening C, Dinter J, Gauss A, Kuehbacher T, Fareed Rahman K, Schiefke I, Schreiber S, Von Amim U, Zeuzem S, Leung WK, Kin Kong Li M, Altorjay I, Bene L, Lakatos P, Molnar T, Salamon A, Schnabel R, Tulassay Z, Avni Y, Barkay O, Fishman S, Goldin E, Keret D, Lahat-Zok A, Melzer E, Naftali T, Nimer A, Ovadia B, Zittan E, Andriulli A, Cappello M, Castiglione F, Danese S, Fries W, Gionchetti P, Kohn A, Maconi G, Santino M, Savarino E, Privitera A, Romano M, Vecchi M, Villa E, Cheon JH, Han DS, Jang BI, Jeen YT, Kim JS, Kim SK, Kim HJ, Kim Y, Lee KM, Lee BI, Park DI, Park YS, Song GA, Ye BD, Pokrotnieks J, Tolmanis I, Denapiene G, Kancauskas A, Jakovlevaite V, Jonaitis L, Cruz Palacios A, Larriva de Los Reyes E, Asela Lujano Nicolas L, Mendoza Fuerte E, D'Haens G, Pierik M, Van Der Woude J, Adrych K, Danilkiewicz WC, Gawdis-Wojnarska B, Hartleb M, Karczewski M, Kierkus J, Malecka-Panas E, Petryka R, Piotrowski W, Regula J, Romatowski J, Rozciecha J, Rydzewska G, Smolinski P, Walczak P, Walczak M, Wozniak-Stolarska B, Cotter J, Lopes L, Portela F, Rodrigues Carvalho J, Simona Gheorghe L, Goldis AE, Mateescu RB, Abdulkhakov R, Agafyina A, Alexeeva O, Alikhanov B, Bunkova E, Dvorkin M, Gubonina I, Kashnikov V, Livzan M, Osipenko M, Parfenov A, Pershko A, Pesegova M, Rafalskiy V, Reshetko O, Simanenkov V, Tsybulko S, Valuyskikh E, Yakovlev A, Cvetkovic M, Damjanov D, Djuranovic S, Dugalic P, Nagorni A, Svorcan P, Zdravkovic Petrovic N, Bunganic I, Gregus M, Hlavaty T, Horvath F, Domenech Morral E, Jover Martinez R, Mendoza MIV, Shieh MJ, Wei CC, Altintas E, Atug O, Gonen C, Hamzaoglu H, Hulagu S, Toruner M, Chopey I, Danyliuk S, Datsenko O, Golovchenko N, Golovchenko O, Hospodarskyy I, Ivanov V, Klymenko V, Levchenko O, Lizogub V, Mostovoy Y, Oliinyk O, Polianskyi I, Pyrohovskyi V, Shevchuk S, Ursol G, Vdovychenko V, Vyshyvanyuk V, Beales I, Brookes M, Nwokolo C, Winter J, Aggarwal A, Aguilar H, Alnoah Z, Arce-Nunez E, Arimie C, Arterburn J, Baum C, Bellaguarda E, Bock B, Boone T, Callahan N, Chapman J, Chen S, Chiorean M, Coates A, Connor M, Dellon S, Dryden G, Du Vall G, Flores L, Fogel R, Frias J, Ginsburg P, Greenberg E, Grunkemeier D, Hellstern P, Herfarth H, Hoffman B, Horst S, Idarraga S, Iskandar H, Jain R, Jenkins E, Kaufman B, Khaleq A, Khan A, Khurana S, Lake J, Leavitt J, Leman B, Lewis D, Lindenberg D, Loftus EV, Korman L, Martin J, McCullough M, McNair A, Mehta N, Mutlu E, Narayen V, Paoli-Bruno J, Perez N, Phillips R, Raijman I, Ramirez-Vega R, Randall C, Rinesmith S, Ritter T, Safdi A, Saltzman M, Sands B, Seminerio J, Schulman M, Sedghi S, Shafran I, Shankar M, Silvers D, Soloman N, Tatum H, Tepper R, Tiongco F, Valdes M, Weber J, Zhang C.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3730::7d5fd2ab3facc13307e74c0e56bd2336
http://hdl.handle.net/11588/780656
Zobrazit plný text záznamu
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
6
Akademický článek
Antitumor Necrosis Factor-like Ligand 1A Therapy Targets Tissue Inflammation and Fibrosis Pathways and Reduces Gut Pathobionts in Ulcerative Colitis.
Autor: Hassan-Zahraee M; Pfizer Inc, Cambridge, MA, USA., Ye Z; Pfizer Inc, Cambridge, MA, USA., Xi L; Pfizer Inc, Cambridge, MA, USA., Baniecki ML; Pfizer Inc, Cambridge, MA, USA., Li X; Pfizer Inc, Cambridge, MA, USA., Hyde CL; Pfizer Inc, Cambridge, MA, USA., Zhang J; Pfizer Inc, Cambridge, MA, USA., Raha N; Pfizer Inc, Cambridge, MA, USA., Karlsson F; Pfizer Inc, Cambridge, MA, USA., Quan J; Pfizer Inc, Cambridge, MA, USA., Ziemek D; Pfizer Inc, Cambridge, MA, USA., Neelakantan S; Pfizer Inc, Cambridge, MA, USA., Lepsy C; Pfizer Inc, Andover, MA, USA., Allegretti JR; Brigham and Women's Hospital, Harvard Medical School, Division of Gastroenterology, Boston, MA, USA., Romatowski J; J. Sniadecki's Regional Hospital, Internal Medicine and Gastroenterology Department, Białystok, Poland., Scherl EJ; Jill Roberts Center for IBD, Weill Cornell Medicine, Division of Gastroenterology and Hepatology, New York, NY, USA., Klopocka M; Nicolaus Copernicus University in Toruń, Collegium Medicum, Department of Gastroenterology and Nutrition, Bydgoszcz, Poland., Danese S; IBD Center, Humanitas Research Hospital, Department of Gastroenterology, Milan, Italy.; Humanitas University, Department of Biomedical Sciences, Milan, Italy., Chandra DE; Pfizer Inc, Cambridge, MA, USA., Schoenbeck U; Pfizer Inc, Cambridge, MA, USA., Vincent MS; Pfizer Inc, Cambridge, MA, USA., Longman R; Jill Roberts Center for IBD, Weill Cornell Medicine, Division of Gastroenterology and Hepatology, New York, NY, USA., Hung KE; Pfizer Inc, Cambridge, MA, USA.
Publikováno v: Inflammatory bowel diseases [Inflamm Bowel Dis] 2022 Mar 02; Vol. 28 (3), pp. 434-446.
Zobrazit plný text záznamu
7
Akademický článek
Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study.
Autor: Danese S; IBD Center, Humanitas Clinical and Research Center-IRCCS, Milan, Italy; Humanitas Research Hospital, Department of Biomedical Sciences, Milan Italy; University Vita-Salute San Raffaele, Milan, Italy. Electronic address: sdanese@hotmail.com., Klopocka M; Nicolaus Copernicus University in Toruń, Collegium Medicum, Department of Gastroenterology and Nutrition, Bydgoszcz, Poland., Scherl EJ; Jill Roberts Center for IBD, Weill Cornell Medicine, Division of Gastroenterology and Hepatology, New York, New York., Romatowski J; J. Sniadecki's Regional Hospital, Internal Medicine and Gastroenterology Department, Białystok, Poland., Allegretti JR; Brigham and Women's Hospital, Harvard Medical School, Division of Gastroenterology, Boston, Massachusetts., Peeva E; Pfizer Inc, Cambridge, Massachusetts., Vincent MS; Pfizer Inc, Cambridge, Massachusetts., Schoenbeck U; Pfizer Inc, New York, New York., Ye Z; Pfizer Inc, Cambridge, Massachusetts., Hassan-Zahraee M; Pfizer Inc, Cambridge, Massachusetts., Rath N; Pfizer Inc, Collegeville, Pennsylvania., Li G; Pfizer Inc, Collegeville, Pennsylvania., Neelakantan S; Pfizer Inc, Cambridge, Massachusetts., Banfield C; Pfizer Inc, Cambridge, Massachusetts., Lepsy C; Pfizer Inc, Andover, Massachusetts., Chandra DE; Pfizer Inc, Cambridge, Massachusetts., Hung KE; Pfizer Inc, Cambridge, Massachusetts.
Publikováno v: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2021 Nov; Vol. 19 (11), pp. 2324-2332.e6. Date of Electronic Publication: 2021 Jun 12.
Zobrazit plný text záznamu
8
Akademický článek
Whipple's disease as a systemic infectious disease -- a case presentation.
Autor: Maciorkowska, M., Ustymowicz, W., Zakrzewski, M., Pryczynicz, A., Markowski, A., Romatowski, J., Guzińska-Ustymowicz, K.
Publikováno v: Progress in Health Sciences; Jun2018, Vol. 8 Issue 1, p213-219, 7p
Zobrazit plný text záznamu
10
Akademický článek
Neuromuscular mechanisms for the fast decline in rate of force development with muscle disuse - a narrative review.
Autor: Ruggiero L; Human Performance Research Centre, Department of Sports Science, University of Konstanz, Konstanz, Germany., Gruber M; Human Performance Research Centre, Department of Sports Science, University of Konstanz, Konstanz, Germany.
Publikováno v: The Journal of physiology [J Physiol] 2024 Oct 28. Date of Electronic Publication: 2024 Oct 28.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje